BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38179653)

  • 21. A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease.
    Khadawardi H; Mura M
    Respirology; 2017 Apr; 22(3):501-507. PubMed ID: 27862639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of radiological pleuroparenchymal fibroelastosis pattern in interstitial lung disease patients registered for lung transplantation: a retrospective cohort study.
    Tanizawa K; Handa T; Kubo T; Chen-Yoshikawa TF; Aoyama A; Motoyama H; Hijiya K; Yoshizawa A; Oshima Y; Ikezoe K; Tokuda S; Nakatsuka Y; Murase Y; Nagai S; Muro S; Oga T; Chin K; Hirai T; Date H
    Respir Res; 2018 Aug; 19(1):162. PubMed ID: 30165854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
    Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
    Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.
    Goh NS; Hoyles RK; Denton CP; Hansell DM; Renzoni EA; Maher TM; Nicholson AG; Wells AU
    Arthritis Rheumatol; 2017 Aug; 69(8):1670-1678. PubMed ID: 28426895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease.
    Caron M; Hoa S; Hudson M; Schwartzman K; Steele R
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29769294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
    Arthritis Rheumatol; 2017 Mar; 69(3):542-549. PubMed ID: 27788297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(5):1-47. PubMed ID: 23074408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Pulmonary Hypertension on Intrahospital Mortality in Lung Transplantation for Interstitial Lung Disease.
    Corral-Blanco M; Prudencio-Ribera VC; Jarrín-Estupiñán ME; Alonso-Moralejo R; Pérez-González V; Meneses-Pardo JC; Hermira-Anchuelo A; De Pablo-Gafas A
    Transplant Proc; 2019 Mar; 51(2):380-382. PubMed ID: 30879546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial impact of weight loss on respiratory function in interstitial lung disease patients with obesity.
    Sekine A; Wasamoto S; Hagiwara E; Yamakawa H; Ikeda S; Okabayashi H; Oda T; Okuda R; Kitamura H; Baba T; Komatsu S; Ogura T
    Respir Investig; 2021 Mar; 59(2):247-251. PubMed ID: 33189601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival of lung transplantation for interstitial lung disease associated with connective tissue diseases: a study of 26 cases from a referral centre.
    Prieto-Peña D; Martínez-Meñaca A; Calderón-Goercke M; Mora-Cuesta VM; Fernández-Rozas S; Iturbe-Fernández D; Gómez-Román JJ; Cifrián-Martínez JM; Castañeda S; Hernández JL; González-Gay MA; Blanco R
    Clin Exp Rheumatol; 2020; 38(4):615-620. PubMed ID: 31694743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease.
    Natalini JG; Diamond JM; Porteous MK; Lederer DJ; Wille KM; Weinacker AB; Orens JB; Shah PD; Lama VN; McDyer JF; Snyder LD; Hage CA; Singer JP; Ware LB; Cantu E; Oyster M; Kalman L; Christie JD; Kawut SM; Bernstein EJ
    J Heart Lung Transplant; 2021 May; 40(5):351-358. PubMed ID: 33637413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary Involvement in the Antisynthetase Syndrome: A Comparative Cross-sectional Study.
    Andersson H; Aaløkken TM; Günther A; Mynarek GK; Garen T; Lund MB; Molberg Ø
    J Rheumatol; 2016 Jun; 43(6):1107-13. PubMed ID: 27036381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process.
    Roofeh D; Barratt SL; Wells AU; Kawano-Dourado L; Tashkin D; Strand V; Seibold J; Proudman S; Brown KK; Dellaripa PF; Doyle T; Leonard T; Matteson EL; Oddis CV; Solomon JJ; Sparks JA; Vassallo R; Maxwell L; Beaton D; Christensen R; Townsend W; Khanna D
    Semin Arthritis Rheum; 2021 Dec; 51(6):1331-1341. PubMed ID: 34493396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis.
    Foeldvari I; Klotsche J; Hinrichs B; Helmus N; Kasapcopur O; Adrovic A; Sztajnbok F; Terreri MT; Anton J; Smith V; Katsicas M; Kostik M; Vasquez-Canizares N; Avcin T; Feldman B; Janarthanan M; Santos MJ; Sawhney S; Schonenberg-Meinema D; Sifuentes-Giraldo WA; Alexeeva E; Appenzeller S; Battagliotti C; Berntson L; Bica B; Costa-Reis P; Eleftheriou D; Kallinich T; Lehman T; Marrani E; Minden K; Nielsen S; Nuruzzaman F; Patwardhan A; Khubchandani R; Stanevicha V; Uziel Y; Torok KS
    Arthritis Care Res (Hoboken); 2022 Mar; 74(3):364-370. PubMed ID: 33141441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.
    Chartrand S; Lee JS; Swigris JJ; Stanchev L; Fischer A
    Lung; 2019 Dec; 197(6):709-713. PubMed ID: 31583453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung transplant for interstitial lung disease: outcomes before and after implementation of the united network for organ sharing lung allocation scoring system.
    De Oliveira NC; Osaki S; Maloney J; Cornwell RD; Meyer KC
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):680-5. PubMed ID: 22219404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How can autoantibodies predict the long-term outcome of patients with interstitial lung disease? Results from a retrospective cohort study.
    Kampolis CF; Venetsanopoulou AI; Karakontaki F; Polychronopoulos V; Vlachoyiannopoulos P; Tzioufas AG
    Autoimmun Rev; 2018 Nov; 17(11):1124-1133. PubMed ID: 30213691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis.
    Schimmelpennink MC; Meek DB; Vorselaars ADM; Langezaal LCM; van Moorsel CHM; van der Vis JJ; Veltkamp M; Grutters JC
    Respir Res; 2022 Jun; 23(1):169. PubMed ID: 35752806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the diagnostic value of a potential screening tool for detecting early interstitial lung disease at the onset of inflammatory rheumatic diseases.
    Hoffmann T; Oelzner P; Franz M; Teichgräber U; Renz D; Förster M; Böttcher J; Kroegel C; Schulze PC; Wolf G; Pfeil A
    Arthritis Res Ther; 2022 May; 24(1):107. PubMed ID: 35551650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of pre-existing acute exacerbation in patients with interstitial lung disease who underwent lung transplantation.
    Kim HH; Kim HC; Shim TS; Ahn JH; Huh JW; Hong SB; Lee GD; Kim DK; Park SI; Choi S
    Respir Res; 2023 Dec; 24(1):307. PubMed ID: 38062465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.